Adia Nutrition, Inc.·Financial Services

Winter Park, Florida--(Newsfile Corp. - April 8, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA), a leader in regenerative medicine, today announced a strategic partnership with a prominent clinic in Atlanta, Georgia. Adia Labs will serve as the exclusive supplier of regenerative products for the clinic's new Autism Spectrum Disorder (ASD) clinical study.

Winter Park, Florida--(Newsfile Corp. - April 1, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA), a leader in regenerative medicine, stem cell therapies, and premium wellness solutions, today announced key highlights from its Form 10-K annual report for the year ended December 31, 2025. The filing marks a pivotal year of operational expansion following the company's successful transition from a dormant shell to an active player in the high-growth regenerative healthcare sector.

Winter Park, Florida--(Newsfile Corp. - March 24, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine through its Adia Med division, is excited to announce a special virtual Zoom presentation happening tonight, Tuesday, March 24, 2026, at 6:00 PM EDT, with the Center for Autism and Related Disabilities (CARD) at the University of Central Florida (UCF). This high-impact session will deliver critical information directly to families, caregivers, and professionals about Adia Med's ongoing clinical study (ClinicalTrials.gov ID: NCT07304440).

Winter Park, Florida--(Newsfile Corp. - March 17, 2026) - Adia Nutrition Inc. (OTCQB: ADIA) is proud to announce that its subsidiary, Adia Med of Winter Park, has appointed Amy Dalrymple, MSN, APRN, FNP-C, a highly experienced aesthetic nurse practitioner and former Mrs. Florida United States, as the leader of its new Regenerative Aesthetics Division.

Orlando, Florida--(Newsfile Corp. - March 9, 2026) - Adia Nutrition's (OTCQB: ADIA) subsidiary, Adia Med, has launched a complete digital refresh of its online presence. Through a strategic partnership with ZenChange Marketing, Adia Med has relaunched its website with a modern, streamlined design focused on transparency, accessibility, and clear information about its investigational studies.

Winter Park, Florida--(Newsfile Corp. - March 3, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a company focused on regenerative medicine and therapeutic solutions, today announced that its subsidiary, Adia Med of Winter Park, LLC, has submitted its final revised protocol to the Institutional Review Board (IRB) for the lower back pain clinical study. To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/10520/286105_img_8679_1.jpg Following the initial protocol submission on February 16, 2026, the IRB provided constructive feedback with positive comments on the overall study design and approach.
Adia Nutrition, Inc. produces probiotic chews and drink mixes. It offers balanced berry, unsweetened green tea, raspberry lemonade slim, lemon lime sport, and orange mango probiotic drink mixes; and berry and lemonade probiotic chews. The company provides its products online, as well as through its nutrition stores. Adia Nutrition, Inc. was formerly known as PivX Solutions Inc. and changed its name to Adia Nutrition, Inc. in May 2004. The company was founded in 1999 and is based in Kurtistown, Hawaii.
Financial Services
Shell Companies
2
2012-04-11
-9.77